How Have Recent Major Launches from Roche, Novartis, and Sanofi-Aventis Performed Across Asia?
The Asian Cancer Market Outlook to 2010 is a new management report which provides an in-depth analysis of growth brands, product sales forecasts, epidemiology and future market leaders over the period 2005-2010 in nine markets; China, Taiwan, South Korea, Singapore, the Philippines, Malaysia, Thailand, Indonesia and India. The differences in economic development and market potential across the region have led to the creation of a dynamic market for branded products, both innovative and non-innovative, and locally imported generic products, both biologic and conventional. The increasing presence of local players in the Asian market highlights the generics threat to major oncology products which marketers need to overcome in order to ensure success. Globally successful products are no longer guaranteed a competitive position in the Asian market; use this latest report to identify the cancer market trends in developed and emerging Asian countries, assess the dominant forces driving market
